Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
15.9%
% of PSCH's 69 holdings also in XPH
25.6%
% of XPH's 43 holdings also in PSCH
Overlap by Weight
Sector Drift (PSCH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PSCH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
CORCEPT THERAPEUTICS INC | 3.2% | 4.8% | 3.2% |
|
ORGANON & CO. | 2.6% | 2.6% | 2.6% |
|
PRESTIGE BRANDS HOLDINGS INC | 2.7% | 2.5% | 2.5% |
|
LIGAND PHARMACEUTICALS-CL B | 1.4% | 1.8% | 1.4% |
|
SUPERNUS PHARMACEUTICALS INC | 1.3% | 2.2% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
PSCH Overweight Relative to XPH
|
GLAUKOS CORP | 5.1% |
|
MERIT MEDICAL SYSTEMS INC | 4.0% |
|
RADNET INC | 3.5% |
|
INSPIRE MEDICAL SYSTEMS, INC. | 3.5% |
 |
ALKERMES PLC | 3.1% |
|
INTEGER HOLDINGS CORPORATION | 3.0% |
|
ADMA BIOLOGICS, INC. | 3.0% |
|
KRYSTAL BIOTECH, INC. | 2.9% |
|
ICU MEDICAL INC | 2.7% |
|
SELECT MEDICAL HOLDINGS CORP | 2.6% |
PSCH Underweight Relative to XPH
|
LONGBOARD PHARMACEUTICALS, INC. | -4.2% |
|
BRISTOL-MYERS SQUIBB CO | -4.1% |
|
JAZZ PHARMACEUTICALS PLC | -4.0% |
|
INTRA-CELLULAR THERAPIES INC | -3.9% |
|
VIATRIS, INC. | -3.9% |
|
AXSOME THERAPEUTICS, INC. | -3.5% |
|
CATALENT INC | -3.5% |
|
PERRIGO CO | -3.4% |
|
ELANCO ANIMAL HEALTH, INC. | -3.4% |
|
EDGEWISE THERAPEUTICS, INC. | -3.4% |